CSTL

CASTLE BIOSCIENCES INC

CSTL·14843C105·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

CSTL (CASTLE BIOSCIENCES INC) is held by 107 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($73.2M), RTW INVESTMENTS, LP ($67.7M), PRINCIPAL FINANCIAL GROUP INC ($43.5M). Net institutional sentiment: Mixed.

107
Holders
Avg rating(23 Elite)
$527M
Total Value
53% (122)
Fund Consensus
61 buying - 54 selling
CSTLSmart Money Verdict
View all
Held by 107 funds
23 elite
Who's Trading
ActivistPOPortolan Capital Management, LLC4.5%May 15, 2026
ActivistRTW Investments, LPRTW Investments, LP9.3%May 15, 2026
InsiderMJMAETZOLD DEREK JSell $26KMay 7, 2026
InsiderMJMAETZOLD DEREK JSell $4KMay 7, 2026
InsiderMJMAETZOLD DEREK JSell $22KMay 7, 2026
InsiderMJMAETZOLD DEREK JSell $4KMay 7, 2026
InsiderMJMAETZOLD DEREK JExercise 6K shMay 7, 2026
InsiderMJMAETZOLD DEREK JSell $117KMay 7, 2026
InsiderMJMAETZOLD DEREK JSell $20KMay 7, 2026
InsiderMJMAETZOLD DEREK JSell $5KMay 7, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
3M(-3.9%)$73.2M0.0%-9.27%
0
Increased
2.8M(+30.4%)$67.7M0.7%-35.14%
53
Decreased
1.8M(-2.1%)$43.5M0.0%-7.61%
0
New
1.2M$28.9M0.0%-13.96%
40
Decreased
1M(-9.1%)$25.5M0.0%+7.97%
0
New
861,771$21.2M0.0%-13.96%
39
Increased
811,324(+30.4%)$19.9M0.0%-1.86%
36
Increased
769,079(+4.4%)$18.9M0.0%+3.86%
30
Increased
728,100(+1.8%)$17.9M0.0%-37.20%
29
Increased
559,583(+137.6%)$13.7M0.0%-11.73%
45
Increased
532,800(+8.1%)$13.1M0.0%-2.60%
30
Decreased
522,127(-0.5%)$12.8M0.0%+18.05%
0
Decreased
455,036(-15.3%)$11.2M0.1%-36.93%
0
Increased
428,934(+110.7%)$10.5M0.0%-7.31%
45
Decreased
377,082(-2.9%)$9.3M0.0%-6.18%
0
Increased
353,319(+14.4%)$8.7M0.0%-2.29%
31
Increased
341,171(+18.8%)$8.4M0.0%-3.35%
32
Decreased
298,941(-39.3%)$7M0.0%+18.76%
0
Increased
273,101(+4.1%)$6.7M0.0%-34.49%
28
Increased
268,535(+31.0%)$6.6M0.0%-7.06%
35

Showing 1-20 of 122

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used